SEC Filings
Filing date | Form | Description | View |
---|---|---|---|
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
DEFA14A | Additional proxy soliciting materials - definitive |
View HTML | |
DEFA14A | Additional proxy soliciting materials - definitive |
View HTML | |
DEFA14A | Additional proxy soliciting materials - definitive |
View HTML | |
DEFA14A | Additional proxy soliciting materials - definitive |
View HTML | |
DEFA14A | Additional proxy soliciting materials - definitive |
View HTML | |
DEFA14A | Additional proxy soliciting materials - definitive |
View HTML | |
EFFECT | EFFECT |
View HTML |
Displaying 821 - 830 of 958 results
Data provided by Kaleidoscope.
For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.